https://www.selleckchem.com/pr....oducts/8-oh-dpat-8-h
ll-trained in adult cardiac surgery are able to achieve acceptable results in their start-up period. To estimate the incidence and susceptible factors of fatal toxic effects related to epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs). PubMed and Embase were thoroughly searched for clinical trials based on the following terms and corresponding Medical Subject Heading ones "erlotinib", "gefitinib", "afatinib", "dacomitinib", "osimertinib", and "non-small-cell lung cancer (NSCLC)". A total of 53 elig
Like
Comment
Share
